Amyris Inc. [NASDAQ: AMRS] closed the trading session at $5.86 on 01/03/22. The day’s price range saw the stock hit a low of $5.525, while the highest price level was $6.3688. The company report on January 3, 2022 that AMYRIS AND IMMUNITYBIO COMPLETE JOINT VENTURE FOR NEXT GENERATION COVID-19 RNA VACCINE.
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, and ImmunityBio (Nasdaq: IBRX), a clinical-stage immunotherapy company, today announced the completion of a previously announced joint venture agreement to accelerate the commercialization of a leading next-generation COVID-19 vaccine.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Amyris and ImmunityBio combine important vaccine technology and manufacturing capabilities in the joint venture. Upon completion of successful human trials and regulatory approval, the joint venture’s goal is to start delivering the second generation vaccine in 2022 as soon as is practically possible with a goal of delivering immunity for COVID-19 and access to underserved parts of the world where current vaccine technology is challenged due to cost and supply chain limitations.
The stocks have a year to date performance of 8.32 percent and weekly performance of 8.92 percent. The stock has been moved at -63.35 percent over the last six months. The stock has performed -1.68 percent around the most recent 30 days and changed -54.04 percent over the most recent 3-months.
If compared to the average trading volume of 6.10M shares, AMRS reached to a volume of 11782356 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Amyris Inc. [AMRS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMRS shares is $20.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMRS stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cowen have made an estimate for Amyris Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 15, 2021. While these analysts kept the previous recommendation, HSBC Securities raised their target price to Buy. The new note on the price target was released on June 01, 2021, representing the official price target for Amyris Inc. stock. Previously, the target price had yet another raise from $11 to $35, while H.C. Wainwright kept a Buy rating on AMRS stock.
The Average True Range (ATR) for Amyris Inc. is set at 0.49, with the Price to Sales ratio for AMRS stock in the period of the last 12 months amounting to 4.94. Price to Free Cash Flow for AMRS in the course of the last twelve months was 39.29 with Quick ratio for the last quarter at 0.40.
AMRS stock trade performance evaluation
Amyris Inc. [AMRS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.92. With this latest performance, AMRS shares dropped by -1.68% in over the last four-week period, additionally sinking by -63.35% over the last 6 months – not to mention a drop of -16.52% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRS stock in for the last two-week period is set at 45.11, with the RSI for the last a single of trading hit 54.03, and the three-weeks RSI is set at 40.56 for Amyris Inc. [AMRS]. The present Moving Average for the last 50 days of trading for this stock 8.20, while it was recorded at 5.43 for the last single week of trading, and 13.09 for the last 200 days.
Amyris Inc. [AMRS]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Amyris Inc. [AMRS] shares currently have an operating margin of -71.29 and a Gross Margin at +45.83. Amyris Inc.’s Net Margin is presently recorded at -182.03.
Additionally, AMRS Total Debt to Total Capital is recorded at 255.68, with Total Debt to Total Assets ending up at 126.65.
Reflecting on the efficiency of the workforce at the company, Amyris Inc. [AMRS] managed to generate an average of -$529,681 per employee. Receivables Turnover for the company is 4.32 with a Total Asset Turnover recorded at a value of 0.90.Amyris Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.40 and a Current Ratio set at 0.60.
Earnings per share (EPS) analysis for Amyris Inc. [AMRS] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMRS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Amyris Inc. go to 30.00%.
Amyris Inc. [AMRS]: Insider Ownership positions
There are presently around $644 million, or 41.90% of AMRS stock, in the hands of institutional investors. The top three institutional holders of AMRS stocks are: BLACKROCK INC. with ownership of 24,003,031, which is approximately 5.141% of the company’s market cap and around 0.50% of the total institutional ownership; VANGUARD GROUP INC, holding 17,748,444 shares of the stock with an approximate value of $96.02 million in AMRS stocks shares; and FARALLON CAPITAL MANAGEMENT LLC, currently with $63.4 million in AMRS stock with ownership of nearly -10.611% of the company’s market capitalization.
Positions in Amyris Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 135 institutional holders increased their position in Amyris Inc. [NASDAQ:AMRS] by around 9,433,897 shares. Additionally, 79 investors decreased positions by around 21,927,058 shares, while 28 investors held positions by with 87,706,982 shares. The mentioned changes placed institutional holdings at 119,067,937 shares, according to the latest SEC report filing. AMRS stock had 59 new institutional investments in for a total of 3,226,067 shares, while 36 institutional investors sold positions of 16,260,269 shares during the same period.